Gene Query: TMEM263

Dataset Description Geneva Score
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 61.61
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 52.46
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 52.46
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 34.38
Gene expression analysis of dengue-infected cells 32.08
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 30.28
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 30.28
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 29.42
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 27.7
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 27.63
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 27.63
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 26.36
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 26.36
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 25.55
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 25.49
MYCi361 regulates MYC target genes 24.37
Cerebellar differentiation in Ataxia-Telangiectasia 24.24
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 23.74
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 23.48
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 22.83
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 22.79
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 22.34
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 22.18
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 21.58
The Genomic Landscape of Atypical Fibroxanthoma 21.34
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 21.14
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 21.12
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 20.99
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 20.57
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 20.2
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 19.95
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 19.78
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 19.75
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 19.7
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 19.64
DJ-1 is dispensable for human stem cell homeostasis 19.47
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 19.35
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 19.35
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 19.07
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 18.66
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 18.65
Sensing self and nonself circular RNAs 18.59
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 18.33
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 18.24
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 18.2
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 17.96
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 17.74
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 17.25
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 17.24
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 17.2
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 17.06
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 16.87
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 16.87
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 16.86
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 16.85
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 16.58
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 16.58
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 16.46
Ribosomal footprinting of MDA-Parental and MDA-LM2 16.4
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 16.2
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 16.05
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 15.95
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 15.84
Ribosomal footprinting of CN34-Parental and CN34-LM1a 15.83
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 15.68
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 15.38
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 15.31
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 15.19
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 15.15
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 14.88
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 14.76
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 14.76
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 14.55
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 14.54
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 14.4
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 14.35
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 14.05
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 13.96
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 13.93
RNA-sequencing in immortalized human mammary epithelial cells 13.93
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 13.88
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 13.75
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 13.74
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 13.59
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 13.52
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 13.5
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 13.46
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 13.37
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 13.27
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 13.27
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 12.93
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 12.92
RNA-Sequencing of HepG2 cells treated with TGFBeta 12.87
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 12.82
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 12.81
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 12.69
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 12.69
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 12.64
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 12.57
Modeling Familial Cancer with iPSC Approaches 12.55
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 12.54
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 12.54
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 12.5
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 12.39
Selective suppression of endothelial cytokine production by progesterone receptor 12.35
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 12.35
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 12.35
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 12.33
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 12.23
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 12.23
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 12.22
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 12.14
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 12.02
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 11.93
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 11.86
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 11.83
HEK293 TFAM Knockout Expression Study 11.83
High-efficiency RNA-based reprogramming of human primary fibroblasts 11.79
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 11.69
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 11.69
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 11.64
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 11.57
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 11.57
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 11.54
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 11.46
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 11.46
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 11.36
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 11.33
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 11.33
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 11.23
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 11.03
Differential gene expression of human melanoma cells [RNA-seq] 11.03
Nrf2 regulated genes in A549 cells 10.95
Identification of Nrf2 regulated genes by RNA sequencing 10.95
Tracking distinct RNA populations using efficient and reversible covalent chemistry 10.91
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 10.89
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 10.89
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 10.83
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 10.8
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 10.78
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 10.77
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 10.75
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 10.75
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 10.69
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 10.58
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 10.56
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 10.52
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 10.42
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 10.4
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 10.38
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 10.32
MicroRNA targetome analysis during HCMV infection 10.27
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 10.23
RNA-Seq of PRMT1 overexpression ECA109 cells 10.19
Illumina Total RNA-seq in HeLa 10.19
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 10.12
Identification of global XBP1s target gene expression in human prostate cancer cells 10.1
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 10.03
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 10.0
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 10.0
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 9.91
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 9.89
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 9.88
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 9.85
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 9.82
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 9.8
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 9.78
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 9.77
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 9.76
Uridylation by TUT4 and TUT7 marks mRNA for degradation 9.75
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 9.74
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 9.71
3’ Uridylation Expands miRNA Target Repertoire 9.7
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 9.7
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 9.7
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 9.69
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 9.65
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 9.63
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 9.63
Functional role of SLIT2 and ROBO1 in trophoblasts 9.62
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 9.54
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 9.54
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 9.53
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 9.5
Postnatal lipids drive hepatocyte maturation 9.48
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 9.45
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 9.44
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 9.39
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 9.38
Differential expression of genes in AD169-infected MRC5. 9.38
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 9.37
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 9.3
RNA Seq of HMVEC under hypoxia 9.3
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 9.3
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 9.18
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 9.15
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 9.15
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 9.15
Gene expression in PANC1 cells treated with Rakicidin 9.12
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 9.12
High level DNA repair gene expression in human ES cells 9.08
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 9.08
Hijacking of stress response machinery by oncogenes in acute leukaemia 9.08
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 9.0
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 9.0
U2AF1 mutations alter splice site recognition in hematological malignancies 8.89
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 8.88
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 8.84
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 8.82
miRNAs affected by antagomiR-17 treatment 8.8
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 8.71
Active translatome profiling with RiboLace in MCF7 cells 8.67
Transcriptome analysis of H9 hESC derived cerebral organoids 8.66
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 8.65
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 8.6
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 8.59
RNA expression analysis upon JMJD1C depletion 8.54
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 8.54
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 8.5
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 8.49
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 8.49
Genome-wide analysis of Dengue virus 2 infected cells 8.48
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 8.48
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 8.48
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 8.47
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 8.47
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 8.46
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 8.45
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 8.45
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 8.4
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 8.35
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 8.35
MCF-7 as a model for functional analysis of breast cancer risk variants 8.32
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 8.31
Differentially expressed genes post knock down of lincDUSP26 8.3
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 8.29
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 8.28
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 8.26
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 8.26
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 8.21
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 8.17
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 8.17
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 8.16
Landscape of H3K4me3 in human CD19 cells 8.14
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 8.11
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 8.11
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 8.06
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 7.99
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 7.99
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 7.97
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 7.96
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 7.89
ARS2 is a general suppressor of pervasive transcription [RNAseq] 7.83
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 7.79
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 7.79
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 7.75
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 7.72
Transciptomic profiling of human fetal lung samples 7.7
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 7.59
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 7.59
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 7.59
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 7.58
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 7.58
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 7.53
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 7.53
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 7.52
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 7.51
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 7.41
U1 snRNP telescripting regulates size-function stratified human genome 7.4
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 7.36
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 7.35
IRF2 is a master regulator of human keratinocyte stem cell fate 7.35
IMP3 regulated gene expression in breast cancer cells 7.32
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 7.31
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 7.25
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 7.2
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 7.15
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 7.12
Genes significantly down or Up-regulated upon RNF219 knockdown 7.09
Genome-wide discovery of human splicing branchpoints [RNAse] 7.09
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 7.08
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 7.04
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 7.02
A549 cells and MSR-A549 cells 7.02
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 6.98
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 6.96
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 6.94
The Genetic Landscape of Diamond-Blackfan Anemia 6.9
Polarized B -cell functions 6.89
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 6.74
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 6.74
Zone dependent distinctive gene expression profile of the normal human liver tissue 6.67
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 6.59
BI Human Reference Epigenome Mapping Project 6.5
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 6.45
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 6.41
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 6.3
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 6.3
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 6.29
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 6.29
X-Ray induced DNA-Hydroxymethylation changes 6.2
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 6.05
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 6.05
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 5.94
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 5.85
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 5.84
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 5.73
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 5.62
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 5.61
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 5.58
RNA-seq of shEZH2 cells 5.58
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 5.53
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 5.53
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 5.49
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 5.49
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 5.46
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 5.43
Interaction between mitoNEET and NAF-1 in cancer cells 5.42
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 5.38
Real-time observation of light-controlled transcription in living cells 5.36
Effect of drugs on transcriptomic profiles 5.3
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 5.25
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 5.18
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 5.14
TAF1 is critical for AE driven leukemogenesis 5.13
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 5.13
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 5.09
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 5.09
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 5.09
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 5.09
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 5.08
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 5.08
Effect of PRDM11 depletion in U2932 cells 5.06
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 5.06
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 5.06
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 5.04
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 4.97
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 4.96
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 4.96
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 4.96
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 4.91
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 4.9
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 4.86
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 4.79
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 4.55
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 4.51
Derivation and differentiation of haploid human embryonic stem cells 4.48
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 4.4
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 4.39
Total RNA-seq in ALL-SIL upon TLX1 knockdown 4.34
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 4.32
RNA-sequencing of human tendon after injury 4.27
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 4.23
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 4.23
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 4.23
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 4.14
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 4.14
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 4.09
RNA sequencing of human mammary epithelial cells 4.07
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 3.97
Gene expression profile of multiple myeloma cell lines treated with CB-5083 3.92
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 3.91
Identification of differentially expressed genes between senescence and senescence bypass cells 3.88
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  3.84
Systematic discovery of endogenous human ribonucleoprotein complexes 3.82
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 3.75
Identification of a LIF-responsive replication-competent human β cell 3.65
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 3.6
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 3.57
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 3.51
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 3.39
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 3.39
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 3.38
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 3.37
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 3.37
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 3.36
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 3.36
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 3.34
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 3.33
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 3.3
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 3.29
RNA Sequencing of Human iPS derived Cardiomyocytes 3.27
Aneuploidy-induced cellular stresses limit autophagic degradation. 3.26
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 3.25
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 3.24
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 3.14
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 3.13
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 3.13
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 3.13
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 3.09
Gene expression regulated by CSA and CSB in neuroblastoma cell line 2.98
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 2.96
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 2.9
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 2.89
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 2.88
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 2.88
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 2.85
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 2.8
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 2.79
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 2.79
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.77
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 2.74
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 2.71
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 2.71
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 2.67
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 2.65
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 2.61
RNA-seq of MDA-MB-231 cells with TET1 knockout 2.54
Zika virus infection reprograms global transcription of host cells to allow sustained infection 2.45
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 2.45
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 2.45
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 2.43
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 2.42
In situ CAPTURE of chromatin interactions by biotinylated dCas9 2.41
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 2.41
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 2.4
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 2.39
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 2.39
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 2.39
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 2.39
Mitochondrial dsRNA triggers antiviral signalling in humans 2.38
single cell RNA-seq from GM12878 (ENCSR673UIY) 2.38
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 2.34
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 2.33
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 2.33
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 2.3
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 2.19
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 2.14
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 2.11
6mer seed toxicity in viral microRNAs 2.03
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 2.01
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 2.0
SOX11 knockdown in B-ALL cell lines 1.97
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 1.92
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.9
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.9
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.89
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 1.86
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 1.86
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.85
mRNA recovered upon RNF219 IP. [RNA-IP] 1.85
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 1.84
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 1.84
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 1.78
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.73
Proteomics identifies a marker signature of MAPKi resistance in melanoma 1.71
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 1.66
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 1.65
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 1.64
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 1.64
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 1.62
DAOY-Notch1/Notch2 knockout: transcriptome comparison 1.62
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 1.6
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.56
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 1.51
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 1.5
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 1.5
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 1.5
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 1.42
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 1.42
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 1.42
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.41
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 1.36
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.31
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  1.31
Bone marrow derived human B cells [normal proB] 1.27
Modulation of nonsense-mediated decay by rapamycin 1.21
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.18
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 1.15
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 1.06
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 1.06
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 1.02
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 0.99
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 0.98
A code of mono-phosphorylation modulates the function of RB. 0.95
Functional role of CPPED1 in trophoblasts. 0.94
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.9
A transcriptome dataset revealing the molecular features of breast cancer stem cells 0.7
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 0.64
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 0.59
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.55
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 0.51
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.43
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 0.42
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.41
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.41
HBEC-shp53-PCHD7 0.31
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.29
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.27
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 0.23
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.19
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 0.19
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 0.17
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.13
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 0.07
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 0.07
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.03
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.03
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.03
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation